AIFA Procedure
AIFA (Italian Drug Agency) is the national authority responsible for the regulation of pharmaceutical products in Italy.
For the EFORT Congress 2027 (19-21 May 2027, Athens, Greece), only Italian pharmaceutical companies attending or supporting the event through any form of sponsorship are required to obtain authorization from AIFA, as per Italian law (Decreto Legislativo 219/06, art. 124).
Non-Italian pharmaceutical companies are not required to follow this procedure.
According to Italian law, this authorization process for Italian companies must be managed by an Italian agency.
FARGO INTERNATIONAL has been appointed as the preferred agency to support Italian sponsors and exhibitors with AIFA-related procedures for the congress.
CONTACT INFORMATION
Fargo International di Giulia Cambria
– P.Iva 07325650484
Email: info@fargointernational.it
IMPORTANT DEADLINES
- First deadline: 9 March 2027 (70 days before the start of the congress).
- Second and final deadline: 19 March 2027 (60 days before the start of the congress).
Italian Companies are strongly advised to contact FARGO Agency as soon as possible.
Please note that the AIFA authorization is NOT necessary when:
- a company promotes only medical devices or food supplements during a congress (products without Marketing Authorization) but subjected to MEDTECH authorization (if the company is associated).
- when a company sponsors a meeting about arguments not related to the use of any of its pharmaceutical products; in this case the company is not allowed to expose or distribute any kind of advertising material during the meeting (Section 9 art. 124 D.L. n.219/06).
